Lineage Cell Therapeutics, Inc. - Common Stock (LCTX)

CUSIP: 53566P109

Q4 2020 13F Holders as of 31 Dec 2020

Holder snapshot 7 signals
Share change
+1,425,444
Put/Call ratio
5.2%
SEC-reported price per share
$1.76
Number of holders
78
Value change
+$3,142,777
Number of buys
34
Open additional details 1 more signal available
Number of sells
23
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
248,782,811

Security key

53566P109

Report period

Q4 2020

Institutions

78

Top holders

10

Ownership snapshot

Top reported holders of LCTX - Lineage Cell Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BROADWOOD CAPITAL INC
Disclosed value leader
BROADWOOD CAPITAL INC
Comparable rows
0/15
Latest evidence
30 Sep 2020
13F Highest disclosed value: $31,849,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BROADWOOD CAPITAL INC has the largest disclosed position value at $31.85M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BROADWOOD CAPITAL INC's linked filing trail.
Disclosed position value Top 5
BROADWOOD CAPITAL INC $31.85M
VANGUARD GROUP INC $4.9M
Defender Capital, LLC. $4.73M
Prescott General Partners LLC $1.73M
BlackRock Finance, Inc. $1.49M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BROADWOOD CAPITAL INC
13F
Company
13F
—
denominator unverified
$31,849,000
34,005,379 shares
— 30 Sep 2020
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$4,896,000
5,228,057 shares
— 30 Sep 2020
Defender Capital, LLC.
13F
Company
13F
—
denominator unverified
$4,729,000
5,048,990 shares
— 30 Sep 2020
Prescott General Partners LLC
13F
Company
13F
—
denominator unverified
$1,734,000
1,851,851 shares
— 30 Sep 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$1,490,000
1,590,865 shares
— 30 Sep 2020
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$956,000
1,021,544 shares
— 30 Sep 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
78
Shares
55,072,841
Rows available
78
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders
65
Q4 2020 holders
78
Holder diff
13
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 value Q4 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .